The Blood Grouping Reagents market in Italy demonstrated fluctuating trends from 2012 to 2022. The market saw a decline from 2012 to 2016, with notable decreases such as the 8.84% drop in 2015. However, from 2017 onwards, the market reversed its trend, showcasing a steady year-on-year growth, peaking at a 23.95% increase in 2017. The consistent upward trajectory continued till 2022, reaching a market value of 92.53 Million US Dollars, with average annual growth rates indicated by CAGRs of 1.18% to 5.64% over the latter years.
Looking into the future, the Blood Grouping Reagents market is expected to maintain its growth trajectory, driven by advancements in diagnostics technology, increasing healthcare awareness, and the rising prevalence of chronic diseases. Other factors to watch include regulatory changes, shifts in healthcare funding, and the impact of emerging markets strategies by leading industry players. As of 2023, the market remains strong, continuing its upward trend seen in recent years.
| # | 16 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 352,470,000 | 2023 | +3.9% | +3.83% | View data |
| 2 | 2 United Kingdom | 110,710,000 | 2023 | +1.38% | +3.83% | View data |
| 3 | 3 Spain | 103,550,000 | 2023 | +3.37% | +4.68% | View data |
| 4 | 4 Italy | 95,043,000 | 2023 | +1.51% | +1.53% | |
| 5 | 5 Brazil | 35,183,000 | 2023 | -3.18% | -3.78% | View data |
| 6 | 6 Poland | 22,266,000 | 2023 | +0.22% | +0.62% | View data |
